Features of the daily profile of blood pressure, taking into account polymorphism of the angiotensin II type 1 receptor gene in patients with arterial hypertension after myocardial infarction

The article presents the results of a study of the daily blood pressure profile, taking into account the polymorphism of the angiotensin II type 1 receptor gene in patients with arterial hypertension with past myocardial infarction. The study involved 36 men with stage III hypertension, grade 1-3 ar...

Full description

Bibliographic Details
Main Authors:	T.V. Kolesnyk, O.V. Fursa
Format:	Article
Language:	English
Published:	Dnipro State Medical University 2022-09-01
Series:	Medičnì Perspektivi
Subjects:	arterial hypertension and myocardial infarction daily blood pressure profiles angiotensin ii type 1 receptor a1166c polymorphism
Online Access:	http://journals.uran.ua/index.php/2307-0404/article/view/265931

Similar Items

ANGIOTENSIN II AND MYOCARDIAL INFARCTION
by: O. P. Shevchenko, et al.
Published: (2016-01-01)

A1166C POLYMORPHISM OF THE GENE FOR ANGIOTENSIN II RECEPTOR 1ST TYPE AND ENDOTHELIAL DYSFUNCTION IN MEN WITH A HISTORY OF MYOCARDIAL INFARCTION IN YOUNG AGE
by: O. A. Berkovich, et al.
Published: (2000-12-01)

PROGNOSTIC ROLE OF A1166C POLYMORPHISMS OF THE ANGIOTENSINE II RECEPTOR GENE (AGT2R1) IN CORONARY ATHEROSCLEROSIS AMONG ADYGHEA REPUBLIC INHABITANTS
by: T. M. Ashkanova, et al.
Published: (2015-10-01)

The effect of aspirin therapy on the plasma renin activity in myocardial infarction
by: M.H Ansari, et al.
Published: (1995-07-01)

Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation
by: Yong Hoon Kim, et al.
Published: (2020-01-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
by: Akif Arslan, et al.
Published: (2016-01-01)

Methyl Bromide Fumigant REDs Regulations Overview
by: Andrew W. MacRae, et al.
Published: (2010-07-01)

THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR?
by: S. Yu. Martsevich
Published: (2016-01-01)

Polymorphisms of LPA gene, rs1801693 and rs7765781, are not associated with premature myocardial infarction in the Iranian population
by: Mahsa Rahimi, et al.
Published: (2021-11-01)

Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension
by: Giovanna Castoldi, et al.
Published: (2021-12-01)

Activities of daily living predict periprocedural myocardial infarction and injury following percutaneous coronary intervention: a cross-sectional study
by: Yifan Pan, et al.
Published: (2023-08-01)

Managing Scale Insects and Mealybugs on Turfgrass
by: Adam G. Dale
Published: (2017-05-01)

C1019T Polymorphism in the Connexin 37 Gene and Myocardial Infarction Risk in Premature Coronary Artery Disease
by: Mehrdad Sheikhvatan, et al.
Published: (2017-05-01)

Biochemical Association of MTHFR C677T Polymorphism with Myocardial Infarction in the Presence of Diabetes Mellitus as a Risk Factor
by: Tauqeer Hussain Mallhi, et al.
Published: (2023-02-01)

Role of genetic polymorphisms associated with lipid disorders and arterial hypertension in the assessment of clinical severity and in-hospital prognosis in patients with ST-segment elevation myocardial infarction
by: A. A. Inozemtseva, et al.
Published: (2015-12-01)

ANALYSIS OF CORRELATION BETWEEN IL 6 GENE POLYMORPHISM (-174 G /C) AND CLASSIC RISK FACTORS IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTIONS
by: A. V. Shevchenko, et al.
Published: (2014-07-01)

PROMOTER POLYMORPHISM OF IL-1β GENE IN PATIENTS WITH A HISTORY OF ACUTE MYOCARDIAL INFARCTION
by: A. V. Shevchenko, et al.
Published: (2014-07-01)

The gene polymorphism of beta1-adrenoreceptor, postinfarction myocardial remodeling and cardiovascular risk: is there any correlation?
by: S. S. Yakushin, et al.
Published: (2018-04-01)

Associations between ambient temperature and acute myocardial infarction
by: Zhao Hong-Ying, et al.
Published: (2018-12-01)

Genetic markers of risk for ST-elevated myocardial infarction
by: N. G. Lozhkina, et al.
Published: (2019-11-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

FEATURES OF HSP70-2 AND HSP70-НОМ GENE POLYMORPHISM IN THE PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION
by: A. V. Shevchenko, et al.
Published: (2014-07-01)

Ginsenoside Re inhibits myocardial fibrosis by regulating miR-489/myd88/NF-κB pathway
by: Jinghui Sun, et al.
Published: (2023-03-01)

Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
by: Shu Jin, et al.
Published: (2023-02-01)

THE STUDY OF RS1800629 (G-308А) POLYMORPHISM OF THE TNF GENE IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ELEVATED ST SEGMENT
by: M. V. Zykov, et al.
Published: (2014-10-01)

Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non‐Obstructive Coronary Arteries
by: Eun Ho Choo, et al.
Published: (2019-07-01)

ASSOCIATION OF COMBINED GENOTYPE OF POLYMORPHIC CYTOKINE GENES SITES, ENDOTHELIAL GROWTH FACTOR AND METALLOPROTEASES WITH MYOCARDIAL INFARCTION DEVELOPMENT IN MEN
by: V. I. Konenkov, et al.
Published: (2014-10-01)

CONSERVATIVE THERAPY IN MYOCARDIAL INFARCTION: THE IMPACT OF GENETIC FACTORS
by: M. V. Solodun
Published: (2016-03-01)

Reperfusion therapy for acute myocardial infarction /
by: Bates, Eric R.
Published: (2008)

Beta-Blocker and Renin–Angiotensin System Inhibitor Combination Therapy in Patients with Acute Myocardial Infarction and Prediabetes or Diabetes Who Underwent Successful Implantation of Newer-Generation Drug-Eluting Stents: A Retrospective Observational Registry Study
by: Yong Hoon Kim, et al.
Published: (2020-10-01)

Vasospastic angina — vasospastic myocardial infarction
by: A. S. Galyavich, et al.
Published: (2020-03-01)

MTHFR gene polymorphisms and susceptibility to myocardial infarction: Evidence from meta-analysis and trial sequential analysis
by: Amir Samii, et al.
Published: (2023-12-01)

Association between Apolipoprotein E polymorphism and myocardial infarction risk: A systematic review and meta‐analysis
by: Yi-Lian Wang, et al.
Published: (2015-01-01)

ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE
by: M. V. Solodun, et al.
Published: (2015-09-01)

PROSPECTS FOR THE USE OF GENOTYPING FOR CHROMOSOME 9p21.3 POLYMORPHISMS FOR MYOCARDIAL INFARCTION RISK STRATIFICATION IN YOUNG PEOPLE
by: P. A. Shesternya, et al.
Published: (2014-07-01)

PROSPECTS FOR THE USE OF GENOTYPING FOR CHROMOSOME 9p21.3 POLYMORPHISMS FOR MYOCARDIAL INFARCTION RISK STRATIFICATION IN YOUNG PEOPLE
by: P. A. Shesternya, et al.
Published: (2014-07-01)

ST-segment elevation myocardial infarction and the clinical significance of differentiated electrocardiogram
by: V. K. Tashchuk, et al.
Published: (2023-05-01)

Common polymorphisms and cardiovascular factors in patients with myocardial infarction of Costa Rica
by: Lizbeth Salazar-Sánchez, et al.
Published: (2006-03-01)